Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Float is pretty much locked up here. One nice PR and we see silverland. IMHO
Then we start skipping pennies as gains!
$RSII
Beautiful charts! Thank you. What are your projections of PPS that we see?
I am confident at least .05
$RSII
haha! Right on! Know what you own, folks!
Welcome aboard the $RSII money train...
$RSII ~ Maybe this could be helpful for ya:
Rising India Inc. Signs Letter of Intent with Rising BioSciences, Inc. for Reverse Merger; Entering the Multi-Billion Dollar Legalized Cannabis Markets
NEW YORK, NY--(Marketwired - Feb 23, 2017) - Rising India Inc. (OTC: RSII) is pleased to announce that it has executed a Letter of Intent with Rising BioSciences, Inc. ("RBI") for a reverse merger in which the capital stockholders of RBI will acquire control of Rising India toward immediate execution of a business model with a focus in alternative medical and cannabis pharmaceutical markets.
Rising India CEO, Jim DiPrima has agreed to resign as an officer with the Company making way for the appointment of Robert Weber, who also serves as CEO for PAO Group, listed on the OTC Markets as New Wave Holdings (OTC: NWAV). (which is now PAOG)
"I am very excited about the plans discussed with Weber thus far and have confidence the merger could provide some thrilling possibilities in terms of shareholder value," stated DiPrima.
Robert Weber agrees, "I feel we have some very favorable circumstances here," states Weber. "There are a number of opportunities in development and marketing of cannabis pharmaceuticals that are synergistic with our endeavors at PAO Group and beyond. Rising Biosciences plans to capitalize on these opportunities toward an assertive growth plan for shareholders alongside a highly expansive business model."
http://www.marketwired.com/press-release/rising-india-inc-signs-letter-intent-with-rising-biosciences-inc-reverse-merger-entering-otc-pink-nwav-2198082.htm
This was the driving force of $RSII hitting .029 last time. It will only go further this time.
I can see that happen! The possibilities are endless.
Also, we are forgetting to mention all the other products that have been produced with samples sent out to selected shareholders. Just based on those sales and FDA approvals, we will hit silverland.
The potential here is quite substantial!
$RSII
We could see Ticker Change ANY DAY now
Reason being that awhile ago they said that ticker change for RSII would be a smoother transition than NWAV to PAOG. That took a while to happen, and upon that single event, PAOG rose to new highs. RSII is due for ticker/name change and hopefully within this week or two. That could send this to .10 IMHO
RSII has already implemented all the new names in their financial reports, websites, and all things affiliated with the company. That was probably the most difficult change that had to be made. Now we are just waiting on FINRA
It is happening! And I believe real real realllll soon!
$RSII
.05+
We will soon have enough revenue to be a Fortune 500 company!
$RSII to the mooonnnn!!!
$RSII ~ Rising India Inc (OTCMKTS:RSII) Advances Cannophen™
Rising India Inc (OTCMKTS:RSII) reported that its Ohio laboratory is close to completion at par with the Ohio state issuing MMJ licenses. Arthur Hall, the COO, expressed that now that Ohio is starting to issue licenses, they intend on being fully functional in their medical marijuana lab, which will emphasis on research, development, manufacturing and licensing of innovative offerings in the Cannabis space committed to serving patients with the best standards.
The details
The COO of Rising India reported that they are also excited to state that comprised in a line of medicinal cannabis offerings, the firm is launching Cannophen™, a revolutionary offering they have been advancing for some time now. Cannophen™ marks as an oral capsule with lab measured metered dosing that can be mixed in exacting ratios of CBD, strain specific terpenes and THC. It is fast acting and easily digestible intended for patients that don’t want to vape/smoke or use off-tasting tinctures.
This enables patients to take their drug by swallowing a capsule. They are also delighted to report a new MMJ form of the TSW pain cream having Cannabidiol. Hall added that there has never been any ideal way to dose with the aforementioned methods. They have advanced Cannophen™ utilizing the strictest control and quality methods and standards established in the pharmacy compounding industry utilizing veteran pharmacists and experienced chemists. Also, Rising Biosciences is approaching completion on its FDA assessment of the TSW pain cream products.
The COO of Rising India expressed that they have also had remarkable feedback from those that obtained study tasters of the Clinical Strength Scar Peptide Serum and they now move into the subsequent phase of production. The company together with PAO Group Inc. is assisting lower the grip of opioids on America by focusing its efforts on the responsible cannabis use.
http://mmjreporter.com/rising-india-inc-otcmktsrsii-advances-cannophen-34664.html
$RSII ~ Rising India Inc (OTCMKTS:RSII) Advances Cannophen™
Rising India Inc (OTCMKTS:RSII) reported that its Ohio laboratory is close to completion at par with the Ohio state issuing MMJ licenses. Arthur Hall, the COO, expressed that now that Ohio is starting to issue licenses, they intend on being fully functional in their medical marijuana lab, which will emphasis on research, development, manufacturing and licensing of innovative offerings in the Cannabis space committed to serving patients with the best standards.
The details
The COO of Rising India reported that they are also excited to state that comprised in a line of medicinal cannabis offerings, the firm is launching Cannophen™, a revolutionary offering they have been advancing for some time now. Cannophen™ marks as an oral capsule with lab measured metered dosing that can be mixed in exacting ratios of CBD, strain specific terpenes and THC. It is fast acting and easily digestible intended for patients that don’t want to vape/smoke or use off-tasting tinctures.
This enables patients to take their drug by swallowing a capsule. They are also delighted to report a new MMJ form of the TSW pain cream having Cannabidiol. Hall added that there has never been any ideal way to dose with the aforementioned methods. They have advanced Cannophen™ utilizing the strictest control and quality methods and standards established in the pharmacy compounding industry utilizing veteran pharmacists and experienced chemists. Also, Rising Biosciences is approaching completion on its FDA assessment of the TSW pain cream products.
The COO of Rising India expressed that they have also had remarkable feedback from those that obtained study tasters of the Clinical Strength Scar Peptide Serum and they now move into the subsequent phase of production. The company together with PAO Group Inc. is assisting lower the grip of opioids on America by focusing its efforts on the responsible cannabis use.
http://mmjreporter.com/rising-india-inc-otcmktsrsii-advances-cannophen-34664.html
We hit that just on announcement of getting into the MMJ industry. What is happening now is bigger... MUCH BIGGER!
$RSII
It was last year that we hit .029
Many longs have been holding on since. And will not sell until .05+
The float is locked. I can see us skipping pennies in no time...
$RSII
With the potential of this pill and the other products it is certainly possible that we end up in dollar land some day. IMHO
$RSII
Party is just getting started Captain!
$RSII
.05+
$RSII ~ Awesome Close!
Welcome back! $RSII back @ it!!
Absolutely! Great to see that!
Higher levels will follow. Way undervalued here. IMO
$RSII
.05+
Wow!!! What a BEAST!!! Near HOD close!
$RSII
FLOAT IS LOCKED! We will be skipping pennies soon!
$RSII
Strap on your seatbelts folks!
Not selling a single share just yet. Way undervalued here.
.05+
$RSII
Party just getting started here...
These aren't just Ihub traders... these are whales taking notice of Cannophen!
$RSII
.05+
$RSII ~ Pennyland, heading to silverland!!!$$$$
FLOAT IS LOCKED AND LOADED
FLOAT IS LOCKED!!! .05+ $$$$$$$$$
Heavy volume and not even 10 minutes in!!!
$RSII
NITE won't last as we RISE like the sun! $RSII
HERE WE GOOO!!!! $$$$$
$RSII
Management has delivered on all of their promises thus far!
Expecting every catalyst to get triggered. Could see dollar land in the future, the way things are going! IMHO
$RSII
Bluesky breakout! Love it. Thanks for the chart!
$RSII
.05+
$RSII ~ Closed @ HOD yesterday +69% w/over 70 million volume breakout!
.05+
Good Morning texaschris22! God bless!
Let's rock n roll!
$RSII
We enter pennyland today!
$RSII
.05+
$RSII ~ Rising Biosciences, Inc. Develops Groundbreaking Oral THC/CBD Delivery Capsule Cannophen; Nears Completion on MMJ Laboratory in Ohio
Sandusky, OH -- January 18, 2018 -- InvestorsHub NewsWire -- Rising India, Inc.'s (OTC: RSII) -- Rising Biosciences, Inc., a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry, is pleased to announce that its laboratory in Ohio is close to completion in line with the State of Ohio issuing MMJ licenses.
"Now that Ohio is beginning to issue licenses, we plan on being fully operational in our medical marijuana laboratory, which will focus on research, development, licensing and manufacturing of innovative products in the Cannabis space dedicated to serving patients with the highest standards," states COO Arthur Hall.
"We are also thrilled to announce that included in a line of medical cannabis products, the company is debuting Cannophen, a revolutionary product we've been developing for some time now. Cannophen is an oral capsule with laboratory controlled metered dosing that can be blended in exacting ratios of THC, CBD and strain specific tirpenes. It is easily digestible and fast acting and designed for patients that do not want to smoke/vape or use off-tasting tinctures. This allows patients to take their medicine by swallowing a flavorless capsule, just like any other oral medication. We are also pleased to announce a new MMJ version of the TSW pain cream containing Cannabidiol (CBD)."
Hall adds, "There has never been any proper way to dose with the above said methods. We have developed Cannophen using the strictest quality and control standards and methods set forth in the pharmacy compounding industry using experienced chemists and veteran pharmacists."
As well, Rising Biosciences is nearing completion on its FDA testing of the TSW (This Sh** Works) pain cream products.
"We've also had stellar feedback from those that received trial samples of the Clinical Strength Scar Peptide Serum and we now move into the next phase of production," concludes Hall.
"Rising Biosciences Inc. along with PAO Group Inc. helping reduce the grip of opiods on America through the responsible use of cannabis"
$RSII on Twitter for LIVE company updates! www.twitter.com/risingindiausa
$RSII ~ Rising Biosciences, Inc. Develops Groundbreaking Oral THC/CBD Delivery Capsule Cannophen; Nears Completion on MMJ Laboratory in Ohio
Sandusky, OH -- January 18, 2018 -- InvestorsHub NewsWire -- Rising India, Inc.'s (OTC: RSII) -- Rising Biosciences, Inc., a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry, is pleased to announce that its laboratory in Ohio is close to completion in line with the State of Ohio issuing MMJ licenses.
"Now that Ohio is beginning to issue licenses, we plan on being fully operational in our medical marijuana laboratory, which will focus on research, development, licensing and manufacturing of innovative products in the Cannabis space dedicated to serving patients with the highest standards," states COO Arthur Hall.
"We are also thrilled to announce that included in a line of medical cannabis products, the company is debuting Cannophen, a revolutionary product we've been developing for some time now. Cannophen is an oral capsule with laboratory controlled metered dosing that can be blended in exacting ratios of THC, CBD and strain specific tirpenes. It is easily digestible and fast acting and designed for patients that do not want to smoke/vape or use off-tasting tinctures. This allows patients to take their medicine by swallowing a flavorless capsule, just like any other oral medication. We are also pleased to announce a new MMJ version of the TSW pain cream containing Cannabidiol (CBD)."
Hall adds, "There has never been any proper way to dose with the above said methods. We have developed Cannophen using the strictest quality and control standards and methods set forth in the pharmacy compounding industry using experienced chemists and veteran pharmacists."
As well, Rising Biosciences is nearing completion on its FDA testing of the TSW (This Sh** Works) pain cream products.
"We've also had stellar feedback from those that received trial samples of the Clinical Strength Scar Peptide Serum and we now move into the next phase of production," concludes Hall.
"Rising Biosciences Inc. along with PAO Group Inc. helping reduce the grip of opiods on America through the responsible use of cannabis"
$RSII on Twitter for LIVE company updates! www.twitter.com/risingindiausa
Party is just getting started...
$RSII
.05+
$RSII ~ MMJ THC Capsule in production! #Cannophen $$$$
Just released 5 new sneak peak photos from the lab!!
https://www.facebook.com/RisingBioSciences/
$RSII ~ MMJ THC Capsule in production! #Cannophen $$$$
Just released 5 new sneak peak photos from the lab!!
https://www.facebook.com/RisingBioSciences/
This run is well overdue! Let's goo!!!! $$$$$$
Very undervalued here! IMHO
.05+
$RSII
$RSII ~ OUTBREAK ALERT!!!
$RSII ~ OUTBREAK ALERT!!!
Just wait until the west coast wakes up... $$$$$$$
$RSII
$RSII ~ New FB posts of new product! High volume being traded this morning!
Rising Biosciences, Inc. Develops Groundbreaking Oral THC/CBD Delivery Capsule Cannophen™; Nears Completion on MMJ Laboratory in Ohio